The Link of Interferon Regulatory Factors 4 and 7 on the Patient's Survival in Lung Adenocarcinoma

被引：0
作者：
Kara, Altan [1 ]
Aydin, Ali [1 ]
Morva, Ahsen [1 ]
Ceker, Dilek [1 ]
Kucuker, Sevde [1 ]
Karadag, Abdullah [1 ]
机构：
[1] TUBITAK Marmara Res Ctr, Mol Oncol Lab, Genet Engn & Biotechnol Inst, Gebze, Turkey
来源：
2018 1ST INTERNATIONAL CONFERENCE ON CANCER CARE INFORMATICS (CCI) | 2018年
关键词：
Non-small cell lung adenocarcinoma; IRF4; IRF7; Oncolytic therapy of non-small cell lung adenocarcinoma; Cancer Care Informatics; TRANSCRIPTION FACTORS; IRF FAMILY; CANCER; EXPRESSION; MUTATIONS; DISCOVERY; IMMUNITY; DATABASE; GENES;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The mechanism behind the development and progression of cancer is complex and largely remained unknown. Recent studies suggest that interferon regulatory factors (IRF) 4 and 7 may play a significant role in carcinogenesis. Alterations on the expression profiles of the IRF4 and IRF7 directly induce pathogen susceptibility in the cell environment resulting in the activation of cancer-related factors required for a number of stages in metastatic cascade. In the present study, we have investigated the role of the IRF4 and IRF7 on the survival of patients with lung adenocarcinoma through genomics and interactome analyses using the data from The Cancer Genome Atlas (TCGA) database. In addition, the possible impact of the damaging mutations on the biological functions of the targeted proteins have been explored.
引用
收藏
页码：55 / 58
页数：4
相关论文
共 28 条
[1]  
[Anonymous], 2013, CURR PROTOC HUM GENE
[2]  
[Anonymous], 2012, Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012
[3]   Lung Cancer and Its Early Detection Using Biomarker-Based Biosensors [J].
Arya, Sunil K. ;
Bhansali, Shekhar .
CHEMICAL REVIEWS, 2011, 111 (11) :6783-6809
[4]   The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website [J].
Bamford, S ;
Dawson, E ;
Forbes, S ;
Clements, J ;
Pettett, R ;
Dogan, A ;
Flanagan, A ;
Teague, J ;
Futreal, PA ;
Stratton, MR ;
Wooster, R .
BRITISH JOURNAL OF CANCER, 2004, 91 (02) :355-358
[5]   A five-gene signature and clinical outcome in non-small-cell lung cancer [J].
Chen, Hsuan-Yu ;
Yu, Sung-Liang ;
Chen, Chun-Houh ;
Chang, Gee-Chen ;
Chen, Chih-Yi ;
Yuan, Ang ;
Cheng, Chiou-Ling ;
Wang, Chien-Hsun ;
Terng, Harn-Jing ;
Kao, Shu-Fang ;
Chan, Wing-Kai ;
Li, Han-Ni ;
Liu, Chun-Chi ;
Singh, Sher ;
Chen, Wei J. ;
Chen, Jeremy J. W. ;
Yang, Pan-Chyr .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :11-20
[6]   Tumor-associated macrophages: Effectors of angiogenesis and tumor progression [J].
Coffelt, Seth B. ;
Hughes, Russell ;
Lewis, Claire E. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1796 (01) :11-18
[7]   Transcription factors as targets for cancer therapy [J].
Darnell, JE .
NATURE REVIEWS CANCER, 2002, 2 (10) :740-749
[8]   A framework for variation discovery and genotyping using next-generation DNA sequencing data [J].
DePristo, Mark A. ;
Banks, Eric ;
Poplin, Ryan ;
Garimella, Kiran V. ;
Maguire, Jared R. ;
Hartl, Christopher ;
Philippakis, Anthony A. ;
del Angel, Guillermo ;
Rivas, Manuel A. ;
Hanna, Matt ;
McKenna, Aaron ;
Fennell, Tim J. ;
Kernytsky, Andrew M. ;
Sivachenko, Andrey Y. ;
Cibulskis, Kristian ;
Gabriel, Stacey B. ;
Altshuler, David ;
Daly, Mark J. .
NATURE GENETICS, 2011, 43 (05) :491-+
[9]   MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data [J].
Fan, Yu ;
Xi, Liu ;
Hughes, Daniel S. T. ;
Zhang, Jianjun ;
Zhang, Jianhua ;
Futreal, P. Andrew ;
Wheeler, David A. ;
Wang, Wenyi .
GENOME BIOLOGY, 2016, 17 :178
[10]   Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway [J].
Graziani, Irene ;
Eliasz, Sandra ;
De Marco, Melissa A. ;
Chen, Yuanbin ;
Pass, Harvey I. ;
De May, Richard M. ;
Strack, Peter R. ;
Miele, Lucio ;
Bocchetta, Maurizio .
CANCER RESEARCH, 2008, 68 (23) :9678-9685
123